Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Yuan

Showing results (1341-1350 of 1,446) with videos related to

Pageof 145
Sort By:
American Journal of Cancer Research|January 12, 2022
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapiesWei-Fan Hsu, Hung-Wei Wang, Cheng-Kuo Chen, et al.
Genome Medicine|July 20, 2021
Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19John F Fullard, Hao-Chih Lee, Georgios Voloudakis, et al.
Journal of Gastroenterology and Hepatology|February 5, 2016
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusWan-Long Chuang, Rong-Nan Chien, Cheng-Yuan Peng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2013
Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancyWendy W Hwang-Verslues, Po-Hao Chang, Yung-Ming Jeng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2018
Efficacy of MaZiRenWan, a Chinese Herbal Medicine, in Patients With Functional Constipation in a Randomized Controlled TrialLinda L D Zhong, Chung-Wah Cheng, Wai Kun, et al.
Nature Communications|June 29, 2022
Regulation of age-associated insulin resistance by MT1-MMP-mediated cleavage of insulin receptorXuanming Guo, Pallavi Asthana, Susma Gurung, et al.
NPJ Parkinson'S Disease|March 29, 2024
Association between irritable bowel syndrome and Parkinson's disease by Cohort study and Mendelian randomization analysisZhi-Yun Wang, Dong-Rui Ma, Meng-Jie Li, et al.
Nature Genetics|February 21, 2017
Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated lociMatthew C Canver, Samuel Lessard, Luca Pinello, et al.
Journal of Hepatology|March 24, 2009
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosageChun-Jen Liu, Po-Huang Lee, Deng-Yn Lin, et al.
Annals of Internal Medicine|August 8, 2022
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort StudyJason Grebely, Gregory J Dore, Frederick L Altice, et al.
Pageof 145

Showing results (1341-1350 of 1,446) with videos related to

Sort By:
Pageof 145
American Journal of Cancer Research|January 12, 2022
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapiesWei-Fan Hsu, Hung-Wei Wang, Cheng-Kuo Chen, et al.
Genome Medicine|July 20, 2021
Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19John F Fullard, Hao-Chih Lee, Georgios Voloudakis, et al.
Journal of Gastroenterology and Hepatology|February 5, 2016
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusWan-Long Chuang, Rong-Nan Chien, Cheng-Yuan Peng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2013
Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancyWendy W Hwang-Verslues, Po-Hao Chang, Yung-Ming Jeng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2018
Efficacy of MaZiRenWan, a Chinese Herbal Medicine, in Patients With Functional Constipation in a Randomized Controlled TrialLinda L D Zhong, Chung-Wah Cheng, Wai Kun, et al.
Nature Communications|June 29, 2022
Regulation of age-associated insulin resistance by MT1-MMP-mediated cleavage of insulin receptorXuanming Guo, Pallavi Asthana, Susma Gurung, et al.
NPJ Parkinson'S Disease|March 29, 2024
Association between irritable bowel syndrome and Parkinson's disease by Cohort study and Mendelian randomization analysisZhi-Yun Wang, Dong-Rui Ma, Meng-Jie Li, et al.
Nature Genetics|February 21, 2017
Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated lociMatthew C Canver, Samuel Lessard, Luca Pinello, et al.
Journal of Hepatology|March 24, 2009
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosageChun-Jen Liu, Po-Huang Lee, Deng-Yn Lin, et al.
Annals of Internal Medicine|August 8, 2022
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort StudyJason Grebely, Gregory J Dore, Frederick L Altice, et al.
Pageof 145